ID   KSCBi002-A-1
AC   CVCL_YN10
SY   GLA-KO hiPS; DGMIFi003-A-1
DR   hPSCreg; KSCBi002-A-1
DR   SKIP; SKIP005607
DR   Wikidata; Q95980247
RX   PubMed=31841972;
CC   From: Daegu-Gyeongbuk Medical Innovation Foundation; Daegu; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 4296; GLA.
CC   Misspelling: KSBCi002-A-1; Note=In Cellosaurus release 34.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT63 ! KSCBi002-A
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 8
//
RX   PubMed=31841972; DOI=10.1016/j.scr.2019.101676;
RA   Kim Y.-K., Yu J.H., Min S.-H., Park S.-W.;
RT   "Generation of a GLA knock-out human-induced pluripotent stem cell
RT   line, KSBCi002-A-1, using CRISPR/Cas9.";
RL   Stem Cell Res. 42:101676-101676(2020).
//